EUVIMEDEUVIMED entdecken
Scoping Review

Substandard and Falsified Medical Products, Devices, and Online Pharmacy Supply-Chain Security: Scoping Review with ☸️SAIMSARA

SAIMSARA Journal · 27.05.2026 · 1 (2)

DOI: 10.62487/saimsarab2913b49 ↗

Kurz gefasst

Scoping Review in der Zeitschrift SAIMSARA Journal, online erschienen am 27.05.2026. Die Arbeit nennt 96 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To map and synthesize original research on falsified medical products, focusing on where they are detected, which product categories and distribution channels are implicated, how they are identified, and what system-level responses are supported by the evidence. The review uses 96 references and builds its evidence map from 71 original studies with 99925 total participants/sample observations (topic-deduplicated ΣN). Across regulatory, laboratory, online, and frontline settings, the evidence suggests that falsified medical products are best understood as a systems-level supply-chain and market-integrity problem rather than a discrete therapeutic-class issue, consistently co-occurring with substandard quality where oversight, affordability, and authentication infrastructure are weakest. Routine multi-country surveillance indicated low but persistent background signals, such as 1.8% probably falsified samples across 13 low- and middle-income countries, whereas targeted online channels showed concentrated risk, including all six illegal online semaglutide products classified as substandard and falsified. Pharmacovigilance signals across 6,302 counterfeit-medicine adverse-event reports further highlight lifestyle, sexual health, and antiviral products as recurrent concerns. These patterns support pairing field-deployable screening and digital reporting with regulatory maturity and equitable access measures. Future research should prioritize harmonized, denominator-based surveillance of online and informal channels linking product testing to patient exposure and enforcement outcomes.

Zitieren

APA

(2026). Substandard and Falsified Medical Products, Devices, and Online Pharmacy Supply-Chain Security: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal, 1(2). https://doi.org/10.62487/saimsarab2913b49

Vancouver

Substandard and Falsified Medical Products, Devices, and Online Pharmacy Supply-Chain Security: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal. 2026;1(2). doi:10.62487/saimsarab2913b49

BibTeX
@article{euvimed2026,
  title = {Substandard and Falsified Medical Products, Devices, and Online Pharmacy Supply-Chain Security: Scoping Review with ☸️SAIMSARA},
  journal = {SAIMSARA Journal},
  year = {2026},
  volume = {1},
  number = {2},
  doi = {10.62487/saimsarab2913b49}
}
Kostenlos starten →